細胞RNA検出の世界市場2018-2022

【英語タイトル】Global Cell RNA Detection Market 2018-2022

Technavioが出版した調査資料(IRTNTR23887)・商品コード:IRTNTR23887
・発行会社(調査会社):Technavio
・発行日:2018年9月28日
・ページ数:111
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
・産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥518,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD5,000 ⇒換算¥740,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、細胞RNA検出の世界市場について調査・分析し、市場概要、市場環境、細胞RNA検出市場規模、エンドユーザー別(医薬品・バイオテクノロジー企業、研究・学術機関、その他)分析、市場動向、競争環境、主要地域別市場規模(北米、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。主な分析対象企業は、Agilent Technologies, Merck KGaA, Promega, QIAGEN, Thermo Fisher Scientificなどです。
・エグゼクティブサマリー
・調査範囲・調査手法
・細胞RNA検出の世界市場概要
・細胞RNA検出の世界市場環境
・細胞RNA検出の世界市場動向
・細胞RNA検出の世界市場規模
・細胞RNA検出の世界市場:業界構造分析
・細胞RNA検出の世界市場:エンドユーザー別(医薬品・バイオテクノロジー企業、研究・学術機関、その他)
・細胞RNA検出の世界市場:地域別市場規模・分析
・細胞RNA検出の北米市場規模・予測
・細胞RNA検出のヨーロッパ・中東・アフリカ市場規模・予測
・細胞RNA検出のアジア太平洋市場規模・予測
・細胞RNA検出の主要国分析
・細胞RNA検出の世界市場:意思決定フレームワーク
・細胞RNA検出の世界市場:成長要因、課題
・細胞RNA検出の世界市場:競争環境
・細胞RNA検出の世界市場:関連企業情報(ベンダー分析)
【レポートの概要】

About Cell RNA Detection Market
Cell RNA detection is performed to understand the behaviour of cell while it is intact. This method enables the dissection of cell in RNA metabolism, RNA transcription, nuclear export, and RNA decay.
Technavio’s analysts forecast the Global Cell RNA Detection Market to grow at a CAGR of 5.76% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the cell RNA detection market. To calculate the market size, the report considers the revenue generated from the cell RNA detection market.

Technavio’s report, cell RNA detection market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Key vendors
• Agilent Technologies
• Merck KGaA
• Promega
• QIAGEN
• Thermo Fisher Scientific

Market driver
• Rising occurrence of cancer
• For a full, detailed list, view our report
Market challenge
• Limited promotional activities
• For a full, detailed list, view our report

Market trend
• Presence of innovative products
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: CUSTOMER LANDSCAPE
PART 08: MARKET SEGMENTATION BY END-USER
• Segmentation by end-user
• Comparison by end-user
• Pharmaceutical and biotechnology companies– Market size and forecast 2017-2022
• Research and academic institutes– Market size and forecast 2017-2022
• Others – Market size and forecast 2017-2022
• Market opportunity by end-user
PART 09: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas – Market size and forecast 2017-2022
• EMEA – Market size and forecast 2017-2022
• APAC – Market size and forecast 2017-2022
• Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 12: MARKET TRENDS
• Growing opportunities in developing nations
• Presence of innovative products
• Growing number of workshops/seminars
PART 13: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Agilent Technologies
• Merck KGaA
• Promega
• QIAGEN
• Thermo Fisher Scientific
PART 15: APPENDIX
• List of abbreviations

Exhibit 01: Parent market
Exhibit 02: Global laboratory equipment market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global cell RNA detection market – Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global cell RNA detection market – Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2017
Exhibit 18: Customer landscape
Exhibit 19: End-user – Market share 2017-2022 (%)
Exhibit 20: Comparison by end-user
Exhibit 21: Pharmaceutical and biotechnology companies– Market size and forecast 2017-2022 ($ mn)
Exhibit 22: Pharmaceutical and biotechnology companies– Year over year growth 2018-2022 (%)
Exhibit 23: Research and academic institutes– Market size and forecast 2017-2022 ($ mn)
Exhibit 24: Research and academic institutes– Year over year growth 2018-2022 (%)
Exhibit 25: Others – Market size and forecast 2017-2022 ($ mn)
Exhibit 26: Others – Year over year growth 2018-2022 (%)
Exhibit 27: Market opportunity by end-user
Exhibit 28: Global cell RNA detection – Market share by geography 2017-2022 (%)
Exhibit 29: Regional comparison
Exhibit 30: Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 31: Americas – Year over year growth 2018-2022 (%)
Exhibit 32: Top three countries in Americas
Exhibit 33: EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 34: EMEA – Year over year growth 2018-2022 (%)
Exhibit 35: Top three countries in EMEA
Exhibit 36: APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 37: APAC – Year over year growth 2018-2022 (%)
Exhibit 38: Top three countries in APAC
Exhibit 39: Market opportunity
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: Agilent Technologies: Overview
Exhibit 46: Agilent Technologies– Business segments
Exhibit 47: Agilent Technologies– Organizational developments
Exhibit 48: Agilent Technologies– Geographic focus
Exhibit 49: Agilent Technologies – Segment focus
Exhibit 50: Agilent Technologies – Key offerings
Exhibit 51: Merck KGaA: Overview
Exhibit 52: Merck KGaA– Business segments
Exhibit 53: Merck KGaA– Organizational developments
Exhibit 54: Merck KGaA – Geographic focus
Exhibit 55: Merck KGaA – Segment focus
Exhibit 56: Merck KGaA– Key offerings
Exhibit 57: Promega: Overview
Exhibit 58: Promega– Business segments
Exhibit 59: Promega– Organizational developments
Exhibit 60: Promega – Geographic focus
Exhibit 61: Promega– Key offerings
Exhibit 62: QIAGEN: Overview
Exhibit 63: QIAGEN– Business segments
Exhibit 64: QIAGEN– Organizational developments
Exhibit 65: QIAGEN – Geographic focus
Exhibit 66: QIAGEN – Segment focus
Exhibit 67: QIAGEN– Key offerings
Exhibit 68: Thermo Fisher Scientific: Overview
Exhibit 69: Thermo Fisher Scientific– Business segments
Exhibit 70: Thermo Fisher Scientific– Organizational developments
Exhibit 71: Thermo Fisher Scientific– Geographic focus
Exhibit 72: Thermo Fisher Scientific– Segment focus
Exhibit 73: Thermo Fisher Scientific– Key offerings



【掲載企業】

Agilent Technologies, Merck KGaA, Promega, QIAGEN, Thermo Fisher Scientific

★調査レポート[細胞RNA検出の世界市場2018-2022] (コード:IRTNTR23887)販売に関する免責事項を必ずご確認ください。
★調査レポート[細胞RNA検出の世界市場2018-2022]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆